Relora, sold in the U.S. since 2000 (US Patent No. 6,582,735), alleviates stress, curbs stress-related eating and promotes weight management by quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness. Relora’s ingredients, a blend of Magnolia officinalis and Phellodendron amurense bark extracts are botanicals that have been used in Traditional Chinese Medicine for thousands of years. In the West, they have been recognized for treating stress. When compared to prescription drugs, Honokiol and Berberine appear effective at calming stress and anxiety without sedative side effects. Relora is Kosher certified by KOF-K (Certification No. 2V04W-QQWYC).
Relora is a powder available for use in capsule form for oral administration, which is produced by Salinas, CA-based Next Pharmaceuticals. Companies located in Canada can purchase Relora through Next Pharmaceuticals’ exclusive distributor, EnZed Nutricorp.